Prediction of individual response to platinum/paclitaxel combination using novel marker genes in ovarian cancers.
作者:
主题词
抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞系, 肿瘤(Cell Line, Tumor);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);基因, 肿瘤(Genes, Neoplasm);人类(Humans);半数抑制浓度(Inhibitory Concentration 50);模型, 生物学(Models, Biological);寡核苷酸序列分析(Oligonucleotide Array Sequence Analysis);卵巢肿瘤(Ovarian Neoplasms);紫杉酚(Paclitaxel);铂(Platinum);预后(Prognosis);治疗结果(Treatment Outcome)
DOI
10.1158/1535-7163.MCT-05-0408
PMID
16546992
发布时间
2020-09-30
- 浏览26
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文